ADJUVANT PARTNERS
Adjuvant Partners is the only life sciences business development and strategic consulting practice.
ADJUVANT PARTNERS
Industry:
Biotechnology Consulting Health Care Life Science
Address:
Towson, Maryland, United States
Country:
United States
Website Url:
http://www.adjuvant.com
Total Employee:
1+
Status:
Active
Contact:
202-345-3675
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta Euro Google Font API Content Delivery Network Pound Sterling Typekit LocalBusiness Schema Squarespace FLoC Opt-Out Cloudflare Turnstile
Similar Organizations
Africa Biosystems Limited
Africa Biosystems Limited provides life sciences equipment and consumables.
Amid Biosciences LLC
Amid Biosciences develops and manufactures products to simplify and improve life science research.
Marcus & Associates | Life Sciences Executive Search Experts
Marcus & Associates is a leading life sciences executive search firm helping clients acquire the industry's' most talented individuals.
Pukana Partners
Pukana Partners is a life sciences business consulting company
The Kinetix Group
The Kinetix Group helps life science companies with healthcare delivery strategies and tactical services.
Current Employees Featured
Official Site Inspections
http://www.adjuvant.com
- Host name: 104.21.23.209
- IP address: 104.21.23.209
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Adjuvant Partners"
Areas of Expertise - Adjuvant Partners
This can take the form of advocacy, education, and network development and is a key component of any private organization seeking government partners or funding. For life sciences government relations services, Adjuvant partners …See details»
Team (archive) - Adjuvant Partners
Prior to founding Adjuvant Partners, he was the Chief Executive Officer of LifeTech Innovations, LLC, a business development consulting firm based in Bethesda, MD. Prior to his position at …See details»
Adjuvant Partners - Crunchbase Company Profile & Funding
Adjuvant Partners collaborates with clients to understand their business strategy and identify novel opportunities for growth. Strategic Planning: Adjuvant Partners helps clients assess and …See details»
Team - Adjuvant Capital
The core and extended Adjuvant teams are anchored by experienced venture capital and private equity investors, global public health leaders, disease-specific technical experts, and …See details»
Adjuvant Capital
Adjuvant is a new type of venture capital firm. We finance the most promising life science technologies for high-burden public health challenges. We see enormous opportunity in historically overlooked market segments, and we leverage our …See details»
Adjuvant Health - Healthcare Consulting | MSO …
Adjuvant.Health was created to help support physicians’ operational and business needs, giving them the time and flexibility to focus on providing exceptional patient care. ... We're a forward-thinking organization that continually searches …See details»
About - Adjuvant Capital
A Commitment to Meaningful, Measurable Public Health Impact and SDG 3. As a signatory of the Operating Principles for Impact Management (the Impact Principles), Adjuvant Capital engaged BlueMark to undertake an independent …See details»
Adjuvant Capital - Crunchbase Investor Profile
Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Adjuvant Capital was …See details»
Services - Adjuvant Partners
Through our network of strategic, venture, and institutional investors, Adjuvant works closely with clients to identify potential investors, and supports the deal making process.* PROJECT MANAGEMENT We support and manage client …See details»
Adjuvant Health - Crunchbase Company Profile & Funding
Adjuvant Health is funded by Ascend Partners. When was the last funding round for Adjuvant Health? Adjuvant Health closed its last funding round on Jan 30, 2023 from a Private Equity …See details»
Adjuvant Partners - Overview, News & Similar companies - ZoomInfo
Oct 27, 2020 The post Adjuvant Capital Closes $300M Venture Fund appeared first on . Feb 18, 2021. www.finsmes.com . Global vaccine adjuvants market size to surpass USD 1,305 million …See details»
Home - Adjuvant
Let our trained and licensed experts help you manage the range of emotions caused by diagnosis, initial treatment, and follow-up cancer scans and screening. Adjuvant’s convenient …See details»
Projects — Adjuvant Partners
Adjuvant orchestrated the launch, program development and membership recruitment for the AAIH. The Result: Within the first year, the organization represents over 30 members across …See details»
Portfolio - Adjuvant Capital
Adjuvant is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public …See details»
Adjuvant Holdings Company Profile - Office Locations ... - Craft
Sep 12, 2024 Adjuvant Holdings has 5 employees at their 1 location and ¥4.44 b in annual revenue in FY 2024. See insights on Adjuvant Holdings including office locations, competitors, …See details»
Novavax Announces Sale of Czech Republic Manufacturing Site to …
1 day ago GAITHERSBURG, Md., Dec. 4, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, …See details»
Antibiotic Adjuvant - Crunchbase Company Profile & Funding
Organization. Antibiotic Adjuvant . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Antibiotic Adjuvant is the only system …See details»
Team — Adjuvant Partners
The collective expertise of our team members ensures our diverse clientele will reach their full potential.See details»
9 Adjuvants Companies Worldwide | Biotech Careers
View the list and locations of 9 biotechnology companies engaged in Adjuvants work. Compounds that improve the ability of a vaccine to stimulate an immune response.See details»
Novavax Announces Sale of Czech Republic Manufacturing Site to …
1 day ago Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it has signed a definitive agreement to sell …See details»